Egypt achieves historic malaria-free certification

The World Health Organization (WHO) has certified Egypt as malaria-free, marking a significant public health milestone for a country with more than 100 million inhabitants.

Duke Health, Microsoft Form 5-Year Generative AI Partnership

What You Should Know: Duke Health forms a strategic five-year, innovative partnership with Microsoft aimed at responsibly and ethically harnessing the potential of generative artificial

August 2, 2023

Is social media derailing our teens? Study unveils the balancing act for adolescent wellbeing

Study delves into the varying impacts of social media on adolescents, distinguishing between healthy, unhealthy, and dependent usage while highlighting a spectrum of personal, interpersonal,

October 4, 2023

Abivax announces update to obefazimod Phase 2b clinical development program in moderately to severely active Crohn’s disease – Biotech Investments

EQS-News: ABIVAX / Key word(s): Study Abivax announces update to obefazimod Phase 2b clinical development program in moderately to severely active Crohn’s disease 02.02.2024 /

February 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.